Four Daiichi Sankyo Blood-Pressure Drugs Given U.S. FDA Warning
This article was originally published in PharmAsia News
Executive Summary
Four Daiichi Sankyo blood-pressure drugs received warnings from U.S. FDA, which said they can cause severe adverse reactions, some leading to hospitalization.